Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
IMTherapeutics
IM Therapeutics develops personalized immuno-therapeutic drugs for autoimmune diseases based on HLA genes.
Sector
Subsector
Keywords
Location
total rounds
total raised
IHP Therapeutics
IHP Therapeutics develops novel glycan therapeutics for cancer and hemolytic diseases.
Sector
Subsector
Keywords
EraCal
EraCal Therapeutics develops cutting-edge drugs to treat diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Kyverna Therapeutics
Kyverna Therapeutics is a company that is developing new therapies and cures for serious autoimmune diseases.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds7
Number of Funding Rounds
Money Raised
Their latest funding was raised on 25.05.2023. Their latest investor Millennium Management. Their latest round Series E
Deep Track Capital
Deep Track Capital is a Greenwich-based investment firm focused on life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Amgen Ventures
Amgen Ventures is a biotech-focused venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Horizons Ventures
Horizons Ventures is a Hong Kong-based venture capital firm that invests in disruptive and technology-focused start-ups.
Sector
Subsector
Location
count Of Investments
count Of Exists
The Column Group
The Column Group is a venture capital firm focused on creating the next generation of biotechnology companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors15
Number of lead investors
Number of investors
Millennium Management
Millennium is a global alternative investment management firm founded in 1989.
Sector
Subsector
Keywords
count Of Investments
count Of Exists
RA Capital Management
RA Capital Management is a Boston-based investment advisor that specializes in the life-sciences and drug development sectors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Derek DiRocco
Derek DiRocco is a Principal on the Investment Team at RA Capital Management. Derek works on both public and private investments and serves as a Board Director for 89Bio, Ltd. Previously, Derek covered solid tumor oncology landscapes. Derek holds a BA in Biology from Holy Cross College and a PhD in Pharmacology from the University of Washington. He conducted his postdoctoral research at Brigham and Women’s Hospital/Harvard Medical School, where he researched the role of the Wnt signaling pathway in mouse models of kidney disease, and was part of a team that discovered a stem cell subtype responsible for solid organ fibrosis.
current job
Frazier Life Sciences
Frazier Life Sciences invests in and builds companies developing novel therapeutics.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders2
Stig K. Hansen
Stig K. Hansen is a Founder & CEO at Carmot Therapeutics.
current job
organization founded
Stig K. Hansen
Daniel A. Erlanson
Daniel Erlanson is VP of Chemistry at Frontier Medicines.
current job
organization founded
Daniel A. Erlanson
Employee Profiles3
Activity
Recent News9
The graph reveals the ratio (%) of positive news articles in a chosen time range